Nalbuphine Hydrochloride Injection
Company:  King Pharmaceuticals, Inc.
Application No.: ANDA 74-471
Approval Date:  3/19/98

• Approval Letter, Final Printed Labeling, Chemistry Review(s), Bioequivalence Review(s), and Microbiology Review(s) (1.1 MB)

• Administrative Documents and Correspondence (2.9 MB)

PDF requires the free Adobe Acrobat Reader

Last updated: June 30, 2005

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research